BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18355689)

  • 1. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans.
    Antenor-Dorsey JA; Markham J; Moerlein SM; Videen TO; Perlmutter JS
    Nucl Med Biol; 2008 Apr; 35(3):335-41. PubMed ID: 18355689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of extrastriatal D2 in vivo specific binding of [¹⁸F](N-methyl)benperidol using PET.
    Eisenstein SA; Koller JM; Piccirillo M; Kim A; Antenor-Dorsey JA; Videen TO; Snyder AZ; Karimi M; Moerlein SM; Black KJ; Perlmutter JS; Hershey T
    Synapse; 2012 Sep; 66(9):770-80. PubMed ID: 22535514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo kinetics of [18F](N-methyl)benperidol: a novel PET tracer for assessment of dopaminergic D2-like receptor binding.
    Moerlein SM; Perlmutter JS; Markham J; Welch MJ
    J Cereb Blood Flow Metab; 1997 Aug; 17(8):833-45. PubMed ID: 9290581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific, reversible binding of [18F]benperidol to baboon D2 receptors: PET evaluation of an improved 18F-labeled ligand.
    Moerlein SM; Perlmutter JS; Welch MJ
    Nucl Med Biol; 1995 Aug; 22(6):809-15. PubMed ID: 8535343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol.
    Eisenstein SA; Antenor-Dorsey JA; Gredysa DM; Koller JM; Bihun EC; Ranck SA; Arbeláez AM; Klein S; Perlmutter JS; Moerlein SM; Black KJ; Hershey T
    Synapse; 2013 Nov; 67(11):748-56. PubMed ID: 23650017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals.
    Nikolaus S; Larisch R; Beu M; Hamacher K; Forutan F; Vosberg H; Müller HW
    J Nucl Med; 2003 Apr; 44(4):618-24. PubMed ID: 12679408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative PET analysis of the dopamine D2 receptor agonist radioligand 11C-(R)-2-CH3O-N-n-propylnorapomorphine in the human brain.
    Otsuka T; Ito H; Halldin C; Takahashi H; Takano H; Arakawa R; Okumura M; Kodaka F; Miyoshi M; Sekine M; Seki C; Nakao R; Suzuki K; Finnema S; Hirayasu Y; Suhara T; Farde L
    J Nucl Med; 2009 May; 50(5):703-10. PubMed ID: 19372485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific binding of 3N-(2'-[18F]fluoroethyl)benperidol to primate cerebral dopaminergic D2 receptors demonstrated in vivo by PET.
    Moerlein SM; Perlmutter JS
    Neurosci Lett; 1992 Dec; 148(1-2):97-100. PubMed ID: 1300511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
    Mukherjee J; Christian BT; Dunigan KA; Shi B; Narayanan TK; Satter M; Mantil J
    Synapse; 2002 Dec; 46(3):170-88. PubMed ID: 12325044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
    Talvik M; Nordström AL; Okubo Y; Olsson H; Borg J; Halldin C; Farde L
    Psychiatry Res; 2006 Dec; 148(2-3):165-73. PubMed ID: 17095199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status.
    Eisenstein SA; Bogdan R; Love-Gregory L; Corral-Frías NS; Koller JM; Black KJ; Moerlein SM; Perlmutter JS; Barch DM; Hershey T
    Synapse; 2016 Oct; 70(10):418-31. PubMed ID: 27241797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol.
    Suehiro M; Dannals RF; Scheffel U; Stathis M; Wilson AA; Ravert HT; Villemagne VL; Sanchez-Roa PM; Wagner HN
    J Nucl Med; 1990 Dec; 31(12):2015-21. PubMed ID: 2148346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of fluorine-18 labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor binding.
    Moerlein SM; Banks WR; Parkinson D
    Int J Rad Appl Instrum A; 1992 Jul; 43(7):913-7. PubMed ID: 1321101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
    Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
    Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates.
    Antenor-Dorsey JA; Laforest R; Moerlein SM; Videen TO; Perlmutter JS
    Eur J Nucl Med Mol Imaging; 2008 Apr; 35(4):771-8. PubMed ID: 18071701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET.
    Nikolaus S; Larisch R; Beu M; Forutan F; Vosberg H; Müller-Gärtner HW
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):390-5. PubMed ID: 12634967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased striatal dopamine receptor binding in primary focal dystonia: a D2 or D3 defect?
    Karimi M; Moerlein SM; Videen TO; Luedtke RR; Taylor M; Mach RH; Perlmutter JS
    Mov Disord; 2011 Jan; 26(1):100-6. PubMed ID: 20960437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.
    Antonini A; Leenders KL; Vontobel P; Maguire RP; Missimer J; Psylla M; Günther I
    Brain; 1997 Dec; 120 ( Pt 12)():2187-95. PubMed ID: 9448574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
    Kumakura Y; Gjedde A; Danielsen EH; Christensen S; Cumming P
    J Cereb Blood Flow Metab; 2006 Mar; 26(3):358-70. PubMed ID: 16079784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.